StockData

Exicure, Inc. (XCUR) stock

XCURNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026Score 4/30
$1.04−0.04 (-3.70%)

Close on Nov 18, 2026Market cap $6.81MP/E –Yield –

Exicure operating income

Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.

Exicure's operating income for the twelve months ending Jun 30, 2026 was -$7.34M. For fiscal 2025 it was -$4.23M. The highest annual figure on record is -$1.83M in fiscal 2022.

Annual operating income

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$4.23M–
FY2024Dec 31, 2024-$12.23M–
FY2023Dec 31, 2023-$15.00M–
FY2022Dec 31, 2022-$1.83M–
FY2021Dec 31, 2021-$62.55M–
FY2020Dec 31, 2020-$25.44M–
FY2019Dec 31, 2019-$26.62M–
FY2018Dec 31, 2018-$21.82M–
FY2017Dec 31, 2017-$10.41M–
FY2016Dec 31, 2016-$16.16M–

Quarterly operating income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$1.05M–
Q1 FY2026Mar 31, 2026-$1.64M-156.1%
Q4 FY2025Dec 31, 2025-$2.26M–
Q3 FY2025Sep 30, 2025-$2.39M–
Q2 FY2025Jun 30, 2025-$2.51M–
Q1 FY2025Mar 31, 2025$2.92M–
Q4 FY2024Dec 31, 2024-$7.59M–
Q3 FY2024Sep 30, 2024-$2.57M–
Q2 FY2024Jun 30, 2024-$1.24M–
Q1 FY2024Mar 31, 2024-$836.00K–
Q4 FY2023Dec 31, 2023-$1.50M-108.1%
Q3 FY2023Sep 30, 2023-$3.32M–
Q2 FY2023Jun 30, 2023-$5.64M–
Q1 FY2023Mar 31, 2023-$4.54M–
Q4 FY2022Dec 31, 2022$18.59M–
Q3 FY2022Sep 30, 2022-$5.21M–
Q2 FY2022Jun 30, 2022-$7.48M–
Q1 FY2022Mar 31, 2022-$7.74M–
Q4 FY2021Dec 31, 2021-$13.45M–
Q3 FY2021Sep 30, 2021-$23.08M–
Q2 FY2021Jun 30, 2021-$13.86M–
Q1 FY2021Mar 31, 2021-$12.16M-2376.6%
Q4 FY2020Dec 31, 2020-$12.46M–
Q3 FY2020Sep 30, 2020-$9.12M–
Q2 FY2020Jun 30, 2020-$4.39M–
Q1 FY2020Mar 31, 2020$534.00K–
Q4 FY2019Dec 31, 2019-$10.11M–
Q3 FY2019Sep 30, 2019-$5.95M–
Q2 FY2019Jun 30, 2019-$4.98M–
Q1 FY2019Mar 31, 2019-$5.58M–
Q4 FY2018Dec 31, 2018-$4.87M–
Q3 FY2018Sep 30, 2018-$5.86M–
Q2 FY2018Jun 30, 2018-$5.80M–
Q1 FY2018Mar 31, 2018-$5.28M–
Q4 FY2017Dec 31, 2017-$3.32M–
Q2 FY2017Aug 31, 2017-$11.90K–
Q4 FY2016Dec 31, 2016-$5.44M–
Q3 FY2016Sep 30, 2016-$3.26M–

More Exicure figures

See a number that looks wrong?